首页> Clinical cancer research : an official journal of the American Association for Cancer Research> The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Maximilian,Lennartz

第一单位： Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.

作者： Maximilian,Lennartz ^[1] ; Sarah,Minner ^[1] ; Sophie,Brasch ^[1] ; Hilko,Wittmann ^[1] ; Leonard,Paterna ^[1] ; Katja,Angermeier ^[1] ; Eray,Öztürk ^[1] ; Rami,Shihada ^[1] ; Mingu,Ruge ^[1] ; Martina,Kluth ^[1] ; Christina,Koop ^[1] ; Waldemar,Wilczak ^[1] ; Till,Krech ^[1] ; Patrick,Lebok ^[1] ; Corinna,Wittmer ^[1] ; Hans,Heinzer ^[2] ; Thomas,Steuber ^[2] ; Meike,Adam ^[2] ; Hartwig,Huland ^[2] ; Markus,Graefen ^[2] ; Alexander,Haese ^[2] ; Ronald,Simon ^[3] ; Guido,Sauter ^[1] ; Thorsten,Schlomm ^[4]

作者单位： Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany. ^[1] Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany. ^[2] Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany. r.simon@uke.de. ^[3] Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany. Department of Urology, Section for Translational Prostate Cancer Research, University Medical Center Hamburg-Eppendorf, Germany. ^[4]